176 related articles for article (PubMed ID: 36268758)
21. Sclerotherapy with 3% polidocanol foam: revolutionizing outpatient treatment in patients with haemorrhoidal disease.
Gallo G; Ronconi M; Trompetto M
Updates Surg; 2021 Oct; 73(5):2029-2030. PubMed ID: 33660166
[No Abstract] [Full Text] [Related]
22. Sclerobanding (Combined Rubber Band Ligation with 3% Polidocanol Foam Sclerotherapy) for the Treatment of Second- and Third-Degree Hemorrhoidal Disease: Feasibility and Short-Term Outcomes.
Pata F; Bracchitta LM; D'Ambrosio G; Bracchitta S
J Clin Med; 2021 Dec; 11(1):. PubMed ID: 35011962
[TBL] [Abstract][Full Text] [Related]
23. [Sclerotherapy of idiopatic hydrocele with polidocanol: a study about 190 cases].
Sallami S; Binous MY; Ben Rhouma S; Chelif M; Hmidi M; Nouira Y; Ben Rais N; Horchani A
Tunis Med; 2011 May; 89(5):440-4. PubMed ID: 21557180
[TBL] [Abstract][Full Text] [Related]
24. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up.
Ouvry P; Allaert FA; Desnos P; Hamel-Desnos C
Eur J Vasc Endovasc Surg; 2008 Sep; 36(3):366-70. PubMed ID: 18524643
[TBL] [Abstract][Full Text] [Related]
25. Polidocanol versus phenol in oil injection sclerotherapy in treatment of internal hemorrhoids: A randomized controlled trial.
Mishra S; Sahoo AK; Elamurugan TP; Jagdish S
Turk J Gastroenterol; 2020 May; 31(5):378-383. PubMed ID: 32519957
[TBL] [Abstract][Full Text] [Related]
26. Polidocanol sclerotherapy for painful venous malformations: evaluation of safety and efficacy in pain relief.
Mimura H; Fujiwara H; Hiraki T; Gobara H; Mukai T; Hyodo T; Iguchi T; Yasui K; Kimata Y; Kanazawa S
Eur Radiol; 2009 Oct; 19(10):2474-80. PubMed ID: 19440712
[TBL] [Abstract][Full Text] [Related]
27. Polidocanol sclerotherapy for hydroceles and epididymal cysts.
Sigurdsson T; Johansson JE; Jahnson S; Helgesen F; Andersson SO
J Urol; 1994 Apr; 151(4):898-901. PubMed ID: 8126821
[TBL] [Abstract][Full Text] [Related]
28. Sclerotherapy for Reticular Veins in the Lower Limbs: A Triple-Blind Randomized Clinical Trial.
Bertanha M; Jaldin RG; Moura R; Pimenta REF; Mariúba JVO; Lúcio Filho CEP; Alcantara GP; Padovani CR; Yoshida WB; Sobreira ML
JAMA Dermatol; 2017 Dec; 153(12):1249-1255. PubMed ID: 28973414
[TBL] [Abstract][Full Text] [Related]
29. Foam sclerotherapy using polidocanol (aethoxysklerol) for preoperative portal vein embolization in 16 patients.
Chung SH; Lee MS; Kim KS; Kim SI; Won JY; Lee DY; Lee KH
Cardiovasc Intervent Radiol; 2011 Dec; 34(6):1236-43. PubMed ID: 21290126
[TBL] [Abstract][Full Text] [Related]
30. The comparison of percutaneous ethanol and polidocanol sclerotherapy in the management of simple renal cysts.
Yonguc T; Sen V; Aydogdu O; Bozkurt IH; Yarimoglu S; Polat S
Int Urol Nephrol; 2015 Apr; 47(4):603-7. PubMed ID: 25778818
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of the efficacy of polidocanol in the form of foam compared with liquid form in sclerotherapy of the greater saphenous vein: initial results.
Hamel-Desnos C; Desnos P; Wollmann JC; Ouvry P; Mako S; Allaert FA
Dermatol Surg; 2003 Dec; 29(12):1170-5; discussion 1175. PubMed ID: 14725657
[TBL] [Abstract][Full Text] [Related]
32. Lingual Arteriovenous Malformation With Bleeding Treated With Polidocanol Foam Sclerotherapy Using Intestinal Forceps to Control Blood Flow.
Sasaki Y; Sasaki S; Ishikawa K
J Craniofac Surg; 2022 May; 33(3):e292-e293. PubMed ID: 34510063
[TBL] [Abstract][Full Text] [Related]
33. Skin hyperpigmentation after sclerotherapy with polidocanol: A systematic review.
Bossart S; Daneluzzi C; Cazzaniga S; Ramelet AA; Uthoff H; Seyed Jafari SM; Baumgartner M; Hunger RE; Heidemeyer K; Willenberg T
J Eur Acad Dermatol Venereol; 2023 Feb; 37(2):274-283. PubMed ID: 36196455
[TBL] [Abstract][Full Text] [Related]
34. Polidocanol Sclerotherapy Combined with Transarterial Embolization Using n-Butyl Cyanoacrylate for Extracranial Arteriovenous Malformations.
Kitagawa A; Yamamoto T; Matsunaga N; Yamaji M; Ikeda S; Izumi Y; Hagihara M; Ota T; Ishiguchi T
Cardiovasc Intervent Radiol; 2018 Jun; 41(6):856-866. PubMed ID: 29417264
[TBL] [Abstract][Full Text] [Related]
35. Endoscopic sclerotherapy with fibrin glue as compared with polidocanol to prevent early esophageal variceal rebleeding.
Zimmer T; Rucktäschel F; Stölzel U; Liehr RM; Schuppan D; Stallmach A; Zeitz M; Weber E; Riecken EO
J Hepatol; 1998 Feb; 28(2):292-7. PubMed ID: 9514542
[TBL] [Abstract][Full Text] [Related]
36. Safety and efficacy of foam sclerotherapy for treatment of low-flow vascular malformations in children.
Markovic JN; Nag U; Shortell CK
J Vasc Surg Venous Lymphat Disord; 2020 Nov; 8(6):1074-1082. PubMed ID: 32284312
[TBL] [Abstract][Full Text] [Related]
37. Successful Sclerotherapy for Cervicofacial Macrocystic Lymphatic Malformations Using Polidocanol and Pingyangmycin Combined Foam Sclerosants.
Wang Q; Zhou Q; Zhao Z; Liu C; Zheng J
Lymphat Res Biol; 2022 Oct; 20(5):507-513. PubMed ID: 35041550
[No Abstract] [Full Text] [Related]
38. Comparison of polidocanol and tetracycline in the sclerotherapy of testicular hydrocele and epididymal cyst.
Daehlin L; Tønder B; Kapstad L
Br J Urol; 1997 Sep; 80(3):468-71. PubMed ID: 9313670
[TBL] [Abstract][Full Text] [Related]
39. Treatment of low-flow vascular malformations by ultrasound-guided sclerotherapy with polidocanol foam: 24 cases and literature review.
Blaise S; Charavin-Cocuzza M; Riom H; Brix M; Seinturier C; Diamand JM; Gachet G; Carpentier PH
Eur J Vasc Endovasc Surg; 2011 Mar; 41(3):412-7. PubMed ID: 21111641
[TBL] [Abstract][Full Text] [Related]
40. Polidocanol Plus Glucose Versus Glucose Alone for the Treatment of Telangiectasias: Triple Blind, Randomised Controlled Trial (PG3T).
Bertanha M; Yoshida WB; Bueno de Camargo PA; Moura R; Reis de Paula D; Padovani CR; Sobreira ML
Eur J Vasc Endovasc Surg; 2021 Jan; 61(1):128-135. PubMed ID: 32778489
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
